Clinical Trial Update: Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) [Phase 3]

View source ↗

Summary

Phase 3 trial update on hypothalamic-pituitary-adrenal axis safety in pediatric perennial allergic rhinitis; the study is completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-10-08